Tariffs, Trade Policy, and the Global Pharma Supply Chain: A Competitive Risk AssessmentAs global trade dynamics shift yet again, the pharmaceutical industry is bracing for impact. Recent tariff developments—particularly the reintroduction of sweeping U.S. import duties—are prompting executives across healthcare and life sciences to revisit their sourcing strategies and cost structures. But beyond the headlines lies a more strategic question: How can competitive intelligence help organizations anticipate,…
Why Competitive Intelligence Is My Secret Weapon in the Biosimilars BattleWorking in the pharmaceutical space, I’ve witnessed firsthand how biosimilars have shifted from a theoretical disruption to a real force reshaping market dynamics. Whether you’re on the innovator side trying to protect share or part of a biosimilar team plotting market entry, one thing has become crystal clear to me: you can’t compete in biosimilars…
Rare Disease & Gene Therapy Commercialization: Why Competitive Intelligence Is My Guiding LightWhen I first started working in the rare disease and gene therapy space, I thought the science would be the hardest part to wrap my head around. And don’t get me wrong—it’s complex. But what I didn’t fully appreciate at the time was just how challenging When I first started working in the rare disease…
Why the Neuroscience Resurgence—Especially in Alzheimer’s and Parkinson’s—Is a Call for Smarter Competitive IntelligenceI’ll admit it—there was a time when neuroscience felt like a graveyard of pharma ambitions. I remember the wave of program terminations, the clinical failures, and the retreat from Alzheimer’s and Parkinson’s pipelines that felt almost industry wide. For a while, neuroscience looked like a losing bet. But now? We’re in the middle of a…
From Raw Data to Revenue: How to Monetize Voice of Customer InsightsHave you ever tried to bake bread from scratch? I mean, really from scratch—not just throwing together a boxed mix, but milling the flour, proofing the yeast, kneading the dough, and waiting patiently for it to rise before baking it to golden perfection. It’s a process. And it’s a lot like turning Voice of the…
Strategy Isn’t Broken – Your Inputs Are!Let’s be honest: Strategy often gets blamed for bad outcomes it had nothing to do with. It’s not the strategy’s fault you missed the competitor’s surprise product drop, or that you priced for last year’s market dynamics, or that you completely whiffed on that new entrant scaling quietly in the background. The strategy didn’t fail.…
Why Competitive Intelligence Fails—And How to Fix ItPicture this: You’re in a high-stakes chess match. The room is silent. The tension is thick. Every move counts. But instead of thinking ahead, you’re fixated on where your opponent used to be five turns ago. You can guess what happens next—you lose. Not because you’re not smart. But because you’re not paying attention to…
The Biggest Misses in Competitor Threat Assessment in Biotech & Pharma—And What to Do About ThemCompetitive intelligence in biotech and pharma isn’t just about tracking pipeline developments—it’s a high-stakes game where missing a key move can cost billions. Yet, time and again, companies fail to anticipate threats because they focus only on obvious competitors, outdated playbooks, or conventional industry players. It’s like preparing for a well-known rival in a championship…
How Competitive Intelligence Tells the Story Behind Pricing ResearchA Preview of My Upcoming Talk: Presenting Pricing Insights That Resonate with Leaders Pricing strategies often rely on robust data—carefully researched, meticulously analyzed, and expertly compiled. Yet, even the most data-driven pricing recommendations can be met with hesitation, skepticism, or outright dismissal when presented to executives. Why? Because pricing isn’t just about the numbers; it’s…
Need Confidence in Your Next Strategic Move?
When critical decisions carry meaningful business implications, our team helps leaders move forward with greater clarity and confidence.
